Common stock only | |
S&P 500 only | |
Director Only | |
10% Owner Only |
Trans Codes
Select...
Amount
-CATALENT
CTLT Insider Trades:
all
Unusual
Whales
Unusual Whales
Unusual Whales
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
Director
10% Owner
Mcap/AUM
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
D - Sale to Issuer
Option to purchase Common Stock
-14,740
1
$11.43B
2024-12-18
2024-12-18
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Common Stock
14,265
$0.00
1
$11.43B
2024-12-18
2024-12-18
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
21,562
$0.00
1
$11.43B
2024-12-18
2024-12-18
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
12,938
$0.00
1
$11.43B
2024-12-18
2024-12-18
HATZFELD MICHAEL
Chief Accounting Officer
A - Grant
Common Stock
3,144
$0.00
1
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
A - Grant
Common Stock
10,722
$0.00
1
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
A - Grant
Common Stock
71,691
$0.00
1
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
A - Grant
Common Stock
11,426
$0.00
1
$11.43B
2024-12-18
2024-12-18
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Common Stock
14,265
$0.00
1
$11.43B
2024-12-18
2024-12-18
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
21,562
$0.00
1
$11.43B
2024-12-18
2024-12-18
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
12,938
$0.00
1
$11.43B
2024-12-18
2024-12-18
HATZFELD MICHAEL
Chief Accounting Officer
A - Grant
Common Stock
3,144
$0.00
1
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
A - Grant
Common Stock
10,722
$0.00
1
$11.43B
2024-12-18
2024-12-18
EVOLI LISA
SVP, Chief HR Officer
D - Sale to Issuer
Options to purchase Common Stock
-14,225
1
$11.43B
2024-12-18
2024-12-18
EVOLI LISA
SVP, Chief HR Officer
D - Sale to Issuer
Common Stock
-51,398
2
$11.43B
2024-12-18
2024-12-18
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
D - Sale to Issuer
Common Stock
-38,232
2
$11.43B
2024-12-18
2024-12-18
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
D - Sale to Issuer
Common Stock
-135K
2
$11.43B
2024-12-18
2024-12-18
GREISCH JOHN
Executive Chair
D - Sale to Issuer
Options to purchase Common Stock
-127K
1
$11.43B
2024-12-18
2024-12-18
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
D - Sale to Issuer
Common Stock
-52,573
2
$11.43B
2024-12-18
2024-12-18
HATZFELD MICHAEL
Chief Accounting Officer
D - Sale to Issuer
Common Stock
-16,676
2
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
D - Sale to Issuer
Options to purchase Common Stock
-26,939
7
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
D - Sale to Issuer
Common Stock
-40,696
2
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
D - Sale to Issuer
Options to purchase Common Stock
-81,082
1
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
D - Sale to Issuer
Common Stock
-148K
2
$11.43B
2024-12-18
2024-12-18
MASELLI ALESSANDRO
President & CEO
D - Sale to Issuer
Options to purchase Common Stock
-224K
8
$11.43B
2024-12-18
2024-12-18
MASELLI ALESSANDRO
President & CEO
D - Sale to Issuer
Common Stock
-291K
2
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
D - Sale to Issuer
Common Stock
-47,730
2
$11.43B
2024-12-18
2024-12-18
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Common Stock
14,265
$0.00
1
$11.43B
2024-12-18
2024-12-18
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
21,562
$0.00
1
$11.43B
2024-12-18
2024-12-18
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
12,938
$0.00
1
$11.43B
2024-12-18
2024-12-18
HATZFELD MICHAEL
Chief Accounting Officer
A - Grant
Common Stock
3,144
$0.00
1
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
A - Grant
Common Stock
10,722
$0.00
1
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
A - Grant
Common Stock
71,691
$0.00
1
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
A - Grant
Common Stock
11,426
$0.00
1
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
A - Grant
Common Stock
71,691
$0.00
1
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
A - Grant
Common Stock
11,426
$0.00
1
$11.43B
2024-12-18
2024-12-18
EVOLI LISA
SVP, Chief HR Officer
D - Sale to Issuer
Options to purchase Common Stock
-14,225
1
$11.43B
2024-12-18
2024-12-18
EVOLI LISA
SVP, Chief HR Officer
D - Sale to Issuer
Common Stock
-51,398
2
$11.43B
2024-12-18
2024-12-18
EVOLI LISA
SVP, Chief HR Officer
D - Sale to Issuer
Options to purchase Common Stock
-14,225
1
$11.43B
2024-12-18
2024-12-18
EVOLI LISA
SVP, Chief HR Officer
D - Sale to Issuer
Common Stock
-51,398
2
$11.43B
2024-12-18
2024-12-18
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
D - Sale to Issuer
Common Stock
-38,232
2
$11.43B
2024-12-18
2024-12-18
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
D - Sale to Issuer
Common Stock
-135K
2
$11.43B
2024-12-18
2024-12-18
GREISCH JOHN
Executive Chair
D - Sale to Issuer
Options to purchase Common Stock
-127K
1
$11.43B
2024-12-18
2024-12-18
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
D - Sale to Issuer
Common Stock
-38,232
2
$11.43B
2024-12-18
2024-12-18
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
D - Sale to Issuer
Common Stock
-135K
2
$11.43B
2024-12-18
2024-12-18
GREISCH JOHN
Executive Chair
D - Sale to Issuer
Options to purchase Common Stock
-127K
1
$11.43B
2024-12-18
2024-12-18
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
D - Sale to Issuer
Common Stock
-52,573
2
$11.43B
2024-12-18
2024-12-18
HATZFELD MICHAEL
Chief Accounting Officer
D - Sale to Issuer
Common Stock
-16,676
2
$11.43B
2024-12-18
2024-12-18
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
D - Sale to Issuer
Common Stock
-52,573
2
$11.43B
2024-12-18
2024-12-18
HATZFELD MICHAEL
Chief Accounting Officer
D - Sale to Issuer
Common Stock
-16,676
2
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
D - Sale to Issuer
Options to purchase Common Stock
-26,939
7
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
D - Sale to Issuer
Common Stock
-40,696
2
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
D - Sale to Issuer
Options to purchase Common Stock
-26,939
7
$11.43B
2024-12-18
2024-12-18
HOPSON RICKY
Pres. BioProduct Delivery, CoS
D - Sale to Issuer
Common Stock
-40,696
2
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
D - Sale to Issuer
Options to purchase Common Stock
-81,082
1
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
D - Sale to Issuer
Common Stock
-148K
2
$11.43B
2024-12-18
2024-12-18
MASELLI ALESSANDRO
President & CEO
D - Sale to Issuer
Options to purchase Common Stock
-224K
8
$11.43B
2024-12-18
2024-12-18
MASELLI ALESSANDRO
President & CEO
D - Sale to Issuer
Common Stock
-291K
2
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
D - Sale to Issuer
Option to purchase Common Stock
-14,740
1
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
D - Sale to Issuer
Common Stock
-47,730
2
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
D - Sale to Issuer
Options to purchase Common Stock
-81,082
1
$11.43B
2024-12-18
2024-12-18
MASANOVICH MATTI
SVP, Chief Financial Officer
D - Sale to Issuer
Common Stock
-148K
2
$11.43B
2024-12-18
2024-12-18
MASELLI ALESSANDRO
President & CEO
D - Sale to Issuer
Options to purchase Common Stock
-224K
8
$11.43B
2024-12-18
2024-12-18
MASELLI ALESSANDRO
President & CEO
D - Sale to Issuer
Common Stock
-291K
2
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
D - Sale to Issuer
Option to purchase Common Stock
-14,740
1
$11.43B
2024-12-18
2024-12-18
MCERLANE DAVID
Group President, Biologics
D - Sale to Issuer
Common Stock
-47,730
2
$11.43B
2024-10-18
2024-10-21
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
S - Sale
Common Stock
-320
$60.00
-19,200
1
$11.43B
2024-10-16
2024-10-16
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
-625
$61.00
-38,125
1
$11.43B
2024-09-26
2024-09-27
MCERLANE DAVID
Group President, Biologics
S - Sale
Common Stock
-1,994
$60.00
-120K
1
$11.43B
2024-08-02
2024-08-05
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
S - Sale
Common Stock
-608
$60.00
-36,480
1
$11.43B
2024-08-02
2024-08-05
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
S - Sale
Common Stock
-1,169
$60.00
-70,140
1
$11.43B
2024-08-02
2024-08-05
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-666
$60.00
-39,960
1
$11.43B
2024-08-02
2024-08-05
HOPSON RICKY
Pres. BioProduct Delivery, CoS
S - Sale
Common Stock
-662
$60.00
-39,720
1
$11.43B
2024-08-02
2024-08-05
EVOLI LISA
SVP, Chief HR Officer
S - Sale
Common Stock
-3,859
$60.00
-232K
1
$11.43B
2024-08-02
2024-08-02
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
-413
$60.00
-24,780
1
$11.43B
2024-07-29
2024-07-30
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
S - Sale
Common Stock
-349
$59.00
-20,591
1
$11.43B
2024-07-29
2024-07-30
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-283
$59.00
-16,697
1
$11.43B
2024-07-29
2024-07-30
HOPSON RICKY
Pres. BioProduct Delivery, CoS
S - Sale
Common Stock
-206
$59.00
-12,154
1
$11.43B
2024-07-29
2024-07-30
MASELLI ALESSANDRO
President & CEO
S - Sale
Common Stock
-9,088
$59.00
-536K
1
$11.43B
2024-07-26
2024-07-30
HATZFELD MICHAEL
Chief Accounting Officer
A - Grant
Common Stock
5,624
$0.00
1
$11.43B
2024-07-26
2024-07-30
HOPSON RICKY
Pres. BioProduct Delivery, CoS
A - Grant
Common Stock
10,225
$0.00
1
$11.43B
2024-07-26
2024-07-30
MASANOVICH MATTI
SVP, Chief Financial Officer
A - Grant
Common Stock
42,604
$0.00
1
$11.43B
2024-07-26
2024-07-30
MCERLANE DAVID
Group President, Biologics
A - Grant
Common Stock
18,746
$0.00
1
$11.43B
2024-07-26
2024-07-30
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Common Stock
17,042
$0.00
1
$11.43B
2024-07-26
2024-07-30
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
18,746
$0.00
1
$11.43B
2024-07-26
2024-07-30
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
11,078
$0.00
1
$11.43B
2024-07-29
2024-07-29
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
-217
$59.00
-12,803
1
$11.43B
2024-07-08
2024-07-10
MASANOVICH MATTI
SVP, Chief Financial Officer
S - Sale
Common Stock
-2,993
$57.00
-171K
1
$11.43B
2024-06-04
2024-06-05
HOPSON RICKY
Pres. BioProduct Delivery, CoS
S - Sale
Common Stock
-1,401
$54.00
-75,654
1
$11.43B
2024-03-15
2024-03-19
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-387
$56.00
-21,672
1
$11.43B
2024-01-16
2024-01-18
HATZFELD MICHAEL
Chief Accounting Officer
A - Grant
Options to purchase Common Stock
3,981
$0.00
1
$11.43B
2024-01-16
2024-01-18
HATZFELD MICHAEL
Chief Accounting Officer
A - Grant
Common Stock
7,908
$0.00
2
$11.43B
2023-12-08
2023-12-12
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
1,505
$0.00
1
$11.43B
2023-12-08
2023-12-12
MASELLI ALESSANDRO
President & CEO
F - Tax
Common Stock
-1,924
$37.00
-71,188
1
$11.43B
2023-12-08
2023-12-12
HOPSON RICKY
Pres. Clinical Dev Supply Div
F - Tax
Common Stock
-256
$37.00
-9,472
1
$11.43B
2023-12-08
2023-12-12
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
F - Tax
Common Stock
-250
$37.00
-9,250
1
$11.43B
2023-12-08
2023-12-12
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
F - Tax
Common Stock
-367
$37.00
-13,579
1
$11.43B
2023-12-08
2023-12-12
HOPSON RICKY
Pres. Clinical Dev Supply Div
A - Grant
Common Stock
747
$0.00
1
$11.43B
2023-12-08
2023-12-12
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
1,023
$0.00
1
$11.43B
2023-08-24
2023-12-12
ARNOLD JONATHAN
SVP, CCO & Div. Head BioP Del.
J - Other
Common Stock
87
1
$11.43B
2023-08-24
2023-12-12
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
J - Other
Common Stock
216
1
$11.43B
2023-08-24
2023-12-12
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
J - Other
Common Stock
396
1
$11.43B
2023-08-24
2023-12-12
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
J - Other
Common Stock
147
1
$11.43B
2023-08-23
2023-12-12
HOPSON RICKY
Pres. Clinical Dev Supply Div
J - Other
Common Stock
-789
$0.00
1
$11.43B
2023-08-23
2023-12-12
FASMAN STEVEN
EVP & Chief Admin Officer
J - Other
Common Stock
-2,226
$0.00
1
$11.43B
2023-08-23
2023-12-12
ARNOLD JONATHAN
SVP, CCO & Div. Head BioP Del.
J - Other
Common Stock
-1,590
$0.00
1
$11.43B
2023-08-23
2023-12-12
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
J - Other
Common Stock
-457
$0.00
1
$11.43B
2023-08-23
2023-12-12
HUNT PATRICIA
Pres. Consumer Health Div
J - Other
Common Stock
-289
$0.00
1
$11.43B
2023-08-23
2023-12-12
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
J - Other
Common Stock
-1,590
$0.00
1
$11.43B
2023-08-23
2023-12-12
PRAVDA RICARDO
Chief Transformation Officer
J - Other
Common Stock
-1,081
$0.00
1
$11.43B
2023-08-23
2023-12-12
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
J - Other
Common Stock
-1,114
$0.00
1
$11.43B
2023-08-23
2023-12-12
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
J - Other
Common Stock
-1,081
$0.00
1
$11.43B
2023-08-23
2023-12-12
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
J - Other
Common Stock
-268
$0.00
1
$11.43B
2023-10-17
2023-10-19
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Options to purchase Common Stock
5,902
$0.00
1
$11.43B
2023-10-17
2023-10-19
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Common Stock
2,708
$0.00
1
$11.43B
2023-10-16
2023-10-18
HUNT PATRICIA
Pres. Consumer Health Div
F - Tax
Common Stock
-22
$47.00
-1,034
1
$11.43B
2023-08-30
2023-09-01
GREISCH JOHN
Executive Chair
A - Grant
Options to purchase Common Stock
127K
$0.00
1
$11.43B
2023-08-30
2023-09-01
GREISCH JOHN
Executive Chair
P - Purchase
Common Stock
21,000
$50.00
1.05M
1
$11.43B
2023-08-24
2023-08-25
ARNOLD JONATHAN
SVP, CCO & Div. Head BioP Del.
S - Sale
Common Stock
-87
$45.00
-3,915
1
$11.43B
2023-08-24
2023-08-25
PRAVDA RICARDO
Chief Transformation Officer
S - Sale
Common Stock
-379
$44.00
-16,676
1
$11.43B
2023-08-24
2023-08-25
MASELLI ALESSANDRO
President & CEO
S - Sale
Common Stock
-2,071
$45.00
-93,195
2
$11.43B
2023-08-24
2023-08-25
HUNT PATRICIA
Pres. Consumer Health Div
S - Sale
Common Stock
-106
$45.00
-4,770
1
$11.43B
2023-08-24
2023-08-25
HOPSON RICKY
Pres. Clinical Dev Supply Div
S - Sale
Common Stock
-276
$45.00
-12,420
1
$11.43B
2023-08-24
2023-08-25
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
Common Stock
-147
$45.00
-6,615
1
$11.43B
2023-08-24
2023-08-25
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-269
$45.00
-12,105
1
$11.43B
2023-08-24
2023-08-25
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-390
$45.00
-17,550
1
$11.43B
2023-08-24
2023-08-25
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
S - Sale
Common Stock
-396
$44.00
-17,424
1
$11.43B
2023-08-24
2023-08-25
FASMAN STEVEN
EVP & Chief Admin Officer
S - Sale
Common Stock
-817
$45.00
-36,765
1
$11.43B
2023-08-24
2023-08-25
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
S - Sale
Common Stock
-216
$45.00
-9,720
1
$11.43B
2023-08-23
2023-08-25
ARNOLD JONATHAN
SVP, CCO & Div. Head BioP Del.
A - Grant
Common Stock
1,590
$0.00
1
$11.43B
2023-08-23
2023-08-25
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
A - Grant
Common Stock
457
$0.00
1
$11.43B
2023-08-23
2023-08-25
FASMAN STEVEN
EVP & Chief Admin Officer
A - Grant
Common Stock
2,226
$0.00
1
$11.43B
2023-08-23
2023-08-25
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
1,590
$0.00
1
$11.43B
2023-08-23
2023-08-25
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
1,114
$0.00
1
$11.43B
2023-08-23
2023-08-25
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
1,081
$0.00
1
$11.43B
2023-08-23
2023-08-25
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
A - Grant
Common Stock
268
$0.00
1
$11.43B
2023-08-23
2023-08-25
HOPSON RICKY
Pres. Clinical Dev Supply Div
A - Grant
Common Stock
789
$0.00
1
$11.43B
2023-08-23
2023-08-25
PRAVDA RICARDO
Chief Transformation Officer
A - Grant
Common Stock
1,081
$0.00
1
$11.43B
2023-08-01
2023-08-03
HUNT PATRICIA
Pres. Consumer Health Div
A - Grant
Options to purchase Common Stock
4,347
$0.00
1
$11.43B
2023-08-01
2023-08-03
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
A - Grant
Common Stock
3,903
$0.00
1
$11.43B
2023-08-01
2023-08-03
FASMAN STEVEN
EVP & Chief Admin Officer
A - Grant
Options to purchase Common Stock
26,473
$0.00
1
$11.43B
2023-08-01
2023-08-03
FASMAN STEVEN
EVP & Chief Admin Officer
A - Grant
Common Stock
11,885
$0.00
1
$11.43B
2023-08-01
2023-08-03
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Options to purchase Common Stock
11,459
$0.00
1
$11.43B
2023-08-01
2023-08-03
FERRARO JOSEPH ANTHONY
SVP, General Counsel, CCO
A - Grant
Common Stock
5,145
$0.00
1
$11.43B
2023-08-01
2023-08-03
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Options to purchase Common Stock
19,756
$0.00
1
$11.43B
2023-08-01
2023-08-03
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
8,870
$0.00
1
$11.43B
2023-08-01
2023-08-03
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Options to purchase Common Stock
13,830
$0.00
1
$11.43B
2023-08-01
2023-08-03
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
6,209
$0.00
1
$11.43B
2023-08-01
2023-08-03
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Options to purchase Common Stock
11,854
$0.00
1
$11.43B
2023-08-01
2023-08-03
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
5,322
$0.00
1
$11.43B
2023-08-01
2023-08-03
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
A - Grant
Options to purchase Common Stock
5,137
$0.00
1
$11.43B
2023-08-01
2023-08-03
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
A - Grant
Common Stock
2,306
$0.00
1
$11.43B
2023-08-01
2023-08-03
HOPSON RICKY
Pres. Clinical Dev Supply Div
A - Grant
Options to purchase Common Stock
10,669
$0.00
1
$11.43B
2023-08-01
2023-08-03
HOPSON RICKY
Pres. Clinical Dev Supply Div
A - Grant
Common Stock
4,790
$0.00
1
$11.43B
2023-08-01
2023-08-03
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
A - Grant
Options to purchase Common Stock
8,693
$0.00
1
$11.43B
2023-08-01
2023-08-03
HUNT PATRICIA
Pres. Consumer Health Div
A - Grant
Common Stock
1,952
$0.00
1
$11.43B
2023-08-01
2023-08-03
LICKFOLD CHARLES
SVP, CIO
A - Grant
Options to purchase Common Stock
11,854
$0.00
1
$11.43B
2023-08-01
2023-08-03
PRAVDA RICARDO
Chief Transformation Officer
A - Grant
Common Stock
9,783
$0.00
1
$11.43B
2023-08-01
2023-08-03
SANTIAGO KAREN MURPHY
VP & Chief Accounting Officer
A - Grant
Options to purchase Common Stock
5,216
$0.00
1
$11.43B
2023-08-01
2023-08-03
SANTIAGO KAREN MURPHY
VP & Chief Accounting Officer
A - Grant
Common Stock
2,342
$0.00
1
$11.43B
2023-08-01
2023-08-03
ZAYAS RICARDO
SVP, Operations, Biologics NA
A - Grant
Options to purchase Common Stock
9,878
$0.00
1
$11.43B
2023-08-01
2023-08-03
ZAYAS RICARDO
SVP, Operations, Biologics NA
A - Grant
Common Stock
4,435
$0.00
1
$11.43B
2023-08-01
2023-08-03
ARNOLD JONATHAN
SVP, CCO & Div. Head BioP Del.
S - Sale
Common Stock
-62
$48.00
-2,976
1
$11.43B
2023-08-01
2023-08-03
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
S - Sale
Common Stock
-383
$48.00
-18,384
1
$11.43B
2023-08-01
2023-08-03
FASMAN STEVEN
EVP & Chief Admin Officer
S - Sale
Common Stock
-1,637
$47.00
-76,939
2
$11.43B
2023-08-01
2023-08-03
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
S - Sale
Common Stock
-281
$48.00
-13,488
2
$11.43B
2023-08-01
2023-08-03
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-276
$48.00
-13,248
2
$11.43B
2023-08-01
2023-08-03
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-190
$48.00
-9,120
1
$11.43B
2023-08-01
2023-08-03
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
Common Stock
-258
$48.00
-12,384
1
$11.43B
2023-08-01
2023-08-03
HOPSON RICKY
Pres. Clinical Dev Supply Div
S - Sale
Common Stock
-195
$48.00
-9,360
1
$11.43B
2023-08-01
2023-08-03
HUNT PATRICIA
Pres. Consumer Health Div
S - Sale
Common Stock
-161
$48.00
-7,728
1
$11.43B
2023-08-01
2023-08-03
MASELLI ALESSANDRO
President & CEO
S - Sale
Common Stock
-1,485
$47.00
-69,795
2
$11.43B
2023-08-01
2023-08-03
PRAVDA RICARDO
Chief Transformation Officer
S - Sale
Common Stock
-269
$48.00
-12,912
2
$11.43B
2023-07-26
2023-07-28
MASELLI ALESSANDRO
President & CEO
A - Grant
Options to purchase Common Stock
103K
$0.00
1
$11.43B
2023-07-05
2023-07-07
MASANOVICH MATTI
SVP, Chief Financial Officer
A - Grant
Options to purchase Common Stock
81,082
$0.00
1
$11.43B
2023-07-05
2023-07-07
MASANOVICH MATTI
SVP, Chief Financial Officer
A - Grant
Common Stock
36,864
$0.00
1
$11.43B
2023-05-01
2023-05-03
BOERMAN MANJA
Pres. BioModalities Division
S - Sale
Common Stock
-1,446
$50.00
-72,300
1
$11.43B
2023-05-01
2023-05-03
GARGIULO MARIO
SVP, Ops, Biologics Europe
S - Sale
Common Stock
-678
$50.00
-33,900
1
$11.43B
2023-01-23
2023-01-25
HOPSON RICKY
Pres. Clinical Dev Supply Div
S - Sale
Common Stock
-643
$49.00
-31,507
1
$11.43B
2022-12-05
2022-12-07
BOERMAN MANJA
Pres. BioModalities Division
S - Sale
Common Stock
-780
$52.00
-40,560
1
$11.43B
2022-10-31
2022-11-02
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-2,451
$66.00
-162K
1
$11.43B
2022-10-10
2022-10-12
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
Common Stock
-930
$77.00
-71,610
1
$11.43B
2022-09-19
2022-09-21
SANTIAGO KAREN MURPHY
VP & Chief Accounting Officer
A - Grant
Options to purchase Common Stock
3,030
$0.00
1
$11.43B
2022-09-19
2022-09-21
SANTIAGO KAREN MURPHY
VP & Chief Accounting Officer
A - Grant
Common Stock
2,421
$0.00
2
$11.43B
2022-08-31
2022-09-02
HOPSON RICKY
Pres. Clinical Dev Supply Div
S - Sale
Common Stock
-2,216
$90.00
-199K
1
$11.43B
2022-08-26
2022-08-30
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-1,639
$104.00
-170K
1
$11.43B
2022-08-26
2022-08-30
RILEY MICHAEL
Pres. Bio Product Delivery Div
S - Sale
Common Stock
-2,491
$104.00
-259K
1
$11.43B
2022-08-25
2022-08-26
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-1,670
$103.00
-172K
1
$11.43B
2022-08-25
2022-08-26
ARNOLD JONATHAN
SVP & Chief Commercial Ofcr
S - Sale
Common Stock
-384
$103.00
-39,552
1
$11.43B
2022-08-25
2022-08-26
BOERMAN MANJA
Pres. BioModalities Division
S - Sale
Common Stock
-3,296
$103.00
-339K
1
$11.43B
2022-08-25
2022-08-26
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
S - Sale
Common Stock
-1,033
$103.00
-106K
1
$11.43B
2022-08-25
2022-08-26
CASTELLANO THOMAS
SVP, Chief Financial Officer
S - Sale
Common Stock
-1,414
$103.00
-146K
1
$11.43B
2022-08-25
2022-08-26
CHIMINSKI JOHN
Executive Chair
S - Sale
Common Stock
-38,934
$103.00
-4.01M
1
$11.43B
2022-08-25
2022-08-26
FASMAN STEVEN
EVP & Chief Admin Officer
S - Sale
Common Stock
-4,811
$103.00
-496K
1
$11.43B
2022-08-25
2022-08-26
GARGIULO MARIO
SVP Global Ops Biologics
S - Sale
Common Stock
-1,586
$103.00
-163K
1
$11.43B
2022-08-25
2022-08-26
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
S - Sale
Common Stock
-1,645
$103.00
-169K
1
$11.43B
2022-08-25
2022-08-26
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-1,840
$103.00
-190K
1
$11.43B
2022-08-25
2022-08-26
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
S - Sale
Common Stock
-671
$103.00
-69,113
1
$11.43B
2022-08-25
2022-08-26
HOPSON RICKY
Pres. Clinical Dev Supply Div
S - Sale
Common Stock
-1,517
$103.00
-156K
1
$11.43B
2022-08-25
2022-08-26
HUNT PATRICIA
Pres. Consumer Health Div
S - Sale
Common Stock
-339
$103.00
-34,917
1
$11.43B
2022-08-25
2022-08-26
MASELLI ALESSANDRO
President & CEO
S - Sale
Common Stock
-4,646
$103.00
-479K
1
$11.43B
2022-08-25
2022-08-26
PRAVDA RICARDO
SVP & Chief HR Officer
S - Sale
Common Stock
-1,747
$103.00
-180K
1
$11.43B
2022-08-25
2022-08-26
RILEY MICHAEL
Pres. Bio Product Delivery Div
S - Sale
Common Stock
-1,482
$103.00
-153K
1
$11.43B
2022-08-25
2022-08-26
SCHMIDT KAY
SVP, Enterprise Functions
S - Sale
Common Stock
-1,321
$103.00
-136K
1
$11.43B
2022-08-24
2022-08-26
ARNOLD JONATHAN
SVP & Chief Commercial Ofcr
A - Grant
Common Stock
6,621
$0.00
1
$11.43B
2022-08-24
2022-08-26
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
5,117
$0.00
1
$11.43B
2022-08-24
2022-08-26
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
4,890
$0.00
1
$11.43B
2022-08-24
2022-08-26
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
6,771
$0.00
1
$11.43B
2022-08-24
2022-08-26
GARGIULO MARIO
SVP Global Ops Biologics
A - Grant
Common Stock
3,432
$0.00
1
$11.43B
2022-08-24
2022-08-26
FASMAN STEVEN
EVP & Chief Admin Officer
A - Grant
Common Stock
10,155
$0.00
1
$11.43B
2022-08-24
2022-08-26
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Common Stock
4,139
$0.00
1
$11.43B
2022-08-24
2022-08-26
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
A - Grant
Common Stock
2,232
$0.00
1
$11.43B
2022-08-24
2022-08-26
RILEY MICHAEL
Pres. Bio Product Delivery Div
A - Grant
Common Stock
3,973
$0.00
1
$11.43B
2022-08-24
2022-08-26
BOERMAN MANJA
Pres. BioModalities Division
A - Grant
Common Stock
6,676
$0.00
1
$11.43B
2022-08-24
2022-08-26
HOPSON RICKY
Pres. Clinical Dev Supply Div
A - Grant
Common Stock
3,733
$0.00
1
$11.43B
2022-08-24
2022-08-26
HAWKESWOOD THOMAS
Pres. Pharma Prod Delivery Div
A - Grant
Common Stock
1,253
$0.00
1
$11.43B
2022-07-27
2022-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-388
$108.00
-41,904
1
$11.43B
2022-07-27
2022-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-394
$108.00
-42,552
1
$11.43B
2022-07-27
2022-07-28
HOPSON RICKY
Pres, Clinical Dev & Supply
S - Sale
Common Stock
-591
$108.00
-63,828
1
$11.43B
2022-07-26
2022-07-28
MASELLI ALESSANDRO
President & CEO
A - Grant
Options to purchase Common Stock
44,427
$0.00
1
$11.43B
2022-07-26
2022-07-28
PRAVDA RICARDO
SVP & Chief HR Officer
A - Grant
Options to purchase Common Stock
5,655
$0.00
1
$11.43B
2022-07-26
2022-07-28
SCHMIDT KAY
SVP, Enterprise Functions
A - Grant
Options to purchase Common Stock
4,847
$0.00
1
$11.43B
2022-07-26
2022-07-28
ARNOLD JONATHAN
SVP & Chief Commercial Ofcr
S - Sale
Common Stock
-94
$107.00
-10,058
1
$11.43B
2022-07-26
2022-07-28
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
S - Sale
Common Stock
-631
$107.00
-67,517
1
$11.43B
2022-07-26
2022-07-28
CASTELLANO THOMAS
SVP, Chief Financial Officer
S - Sale
Common Stock
-347
$107.00
-37,129
1
$11.43B
2022-07-26
2022-07-28
CHIMINSKI JOHN
Executive Chair
S - Sale
Common Stock
-9,691
$107.00
-1.04M
1
$11.43B
2022-07-26
2022-07-28
FASMAN STEVEN
EVP & Chief Admin Officer
S - Sale
Common Stock
-2,546
$107.00
-272K
1
$11.43B
2022-07-26
2022-07-28
GARGIULO MARIO
SVP Global Ops Biologics
S - Sale
Common Stock
-969
$107.00
-104K
1
$11.43B
2022-07-26
2022-07-28
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
S - Sale
Common Stock
-403
$107.00
-43,121
1
$11.43B
2022-07-26
2022-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-450
$107.00
-48,150
1
$11.43B
2022-07-26
2022-07-28
HOPSON RICKY
Pres, Clinical Dev & Supply
S - Sale
Common Stock
-312
$107.00
-33,384
1
$11.43B
2022-07-26
2022-07-28
MASELLI ALESSANDRO
President & CEO
S - Sale
Common Stock
-816
$107.00
-87,312
1
$11.43B
2022-07-26
2022-07-28
PRAVDA RICARDO
SVP & Chief HR Officer
S - Sale
Common Stock
-427
$107.00
-45,689
1
$11.43B
2022-07-26
2022-07-28
SCHMIDT KAY
SVP, Enterprise Functions
S - Sale
Common Stock
-323
$107.00
-34,561
1
$11.43B
2022-07-26
2022-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-409
$107.00
-43,763
1
$11.43B
2022-07-26
2022-07-28
ARNOLD JONATHAN
SVP & Chief Commercial Ofcr
A - Grant
Options to purchase Common Stock
4,443
$0.00
1
$11.43B
2022-07-26
2022-07-28
ARNOLD JONATHAN
SVP & Chief Commercial Ofcr
A - Grant
Common Stock
1,023
$0.00
1
$11.43B
2022-07-26
2022-07-28
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
A - Grant
Options to purchase Common Stock
3,635
$0.00
1
$11.43B
2022-07-26
2022-07-28
CARLETTI LORENZO
SVP Global Ops Ph & Cons Hlth
A - Grant
Common Stock
837
$0.00
1
$11.43B
2022-07-26
2022-07-28
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Options to purchase Common Stock
10,097
$0.00
1
$11.43B
2022-07-26
2022-07-28
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Common Stock
2,323
$0.00
1
$11.43B
2022-07-26
2022-07-28
FASMAN STEVEN
EVP & Chief Admin Officer
A - Grant
Options to purchase Common Stock
12,117
$0.00
1
$11.43B
2022-07-26
2022-07-28
FASMAN STEVEN
EVP & Chief Admin Officer
A - Grant
Common Stock
2,788
$0.00
1
$11.43B
2022-07-26
2022-07-28
GARGIULO MARIO
SVP Global Ops Biologics
A - Grant
Options to purchase Common Stock
3,635
$0.00
1
$11.43B
2022-07-26
2022-07-28
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Options to purchase Common Stock
8,078
$0.00
1
$11.43B
2022-07-26
2022-07-28
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
1,859
$0.00
1
$11.43B
2022-07-26
2022-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Options to purchase Common Stock
5,655
$0.00
1
$11.43B
2022-07-26
2022-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
1,301
$0.00
1
$11.43B
2022-07-26
2022-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Options to purchase Common Stock
4,847
$0.00
1
$11.43B
2022-07-26
2022-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
1,115
$0.00
1
$11.43B
2022-07-26
2022-07-28
HOPSON RICKY
Pres, Clinical Dev & Supply
A - Grant
Options to purchase Common Stock
2,828
$0.00
1
$11.43B
2022-07-26
2022-07-28
HOPSON RICKY
Pres, Clinical Dev & Supply
A - Grant
Common Stock
651
$0.00
1
$11.43B
2022-07-01
2022-07-05
ARNOLD JONATHAN
SVP & Chief Commercial Ofcr
A - Grant
Common Stock
2,804
$107.00
300K
1
$11.43B
2022-07-01
2022-07-05
GENNADIOS ARISTIPPOS
Group Pres. Pharma & Consumer
A - Grant
Common Stock
18,689
$107.00
2.00M
1
$11.43B
2022-06-10
2022-06-13
FASMAN STEVEN
SVP & General Counsel
S - Sale
Common Stock
-5,000
$107.00
-535K
2
$11.43B
2022-06-10
2022-06-13
GARGIULO MARIO
SVP Global Ops Large Molecule
S - Sale
Common Stock
-118
$107.00
-12,626
1
$11.43B
2022-01-31
2022-02-01
HOPSON RICKY
VP, Chief Accounting Officer
S - Sale
Common Stock
-2,325
$103.00
-239K
1
$11.43B
2022-01-10
2022-01-11
FLYNN KAREN
Chief Commercial Officer
S - Sale
Common Stock
-2,472
$117.00
-289K
1
$11.43B
2022-01-03
2022-01-05
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
A - Grant
Common Stock
4,017
$0.00
1
$11.43B
2022-01-03
2022-01-05
GENNADIOS ARISTIPPOS
President Softgel & Oral Tech
A - Grant
Common Stock
4,017
$0.00
1
$11.43B
2022-01-03
2022-01-05
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
4,017
$0.00
1
$11.43B
2022-01-03
2022-01-05
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
4,017
$0.00
1
$11.43B
2021-11-18
2021-12-01
ZIPPELIUS PETER
C - Conversion
Series A Convertible Preferred Stock
-385K
$50.00
-19M
1
$11.43B
2021-11-01
2021-11-03
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
M - Exercise
Options to purchase Common Stock
-7,559
$0.00
4
$11.43B
2021-11-01
2021-11-03
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
M - Exercise
Common Stock
7,559
$45.00
340K
4
$11.43B
2021-11-01
2021-11-03
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
S - Sale
Common Stock
-10,672
$140.00
-1.49M
1
$11.43B
2021-10-20
2021-10-21
CASTELLANO THOMAS
SVP, Chief Financial Officer
S - Sale
Common Stock
-2,307
$134.00
-309K
1
$11.43B
2021-10-14
2021-10-18
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
S - Sale
Common Stock
-1,661
$129.00
-214K
1
$11.43B
2021-10-04
2021-10-06
FASMAN STEVEN
SVP & General Counsel
M - Exercise
Options to purchase Common Stock
-17,259
$0.00
4
$11.43B
2021-10-04
2021-10-06
FASMAN STEVEN
SVP & General Counsel
M - Exercise
Common Stock
17,259
$52.00
897K
4
$11.43B
2021-10-04
2021-10-06
FASMAN STEVEN
SVP & General Counsel
S - Sale
Common Stock
-34,714
$129.00
-4.48M
4
$11.43B
2021-10-04
2021-10-06
SCHMIDT KAY
SVP, Technical Operations
S - Sale
Common Stock
-2,191
$131.00
-287K
1
$11.43B
2021-10-01
2021-10-05
PRAVDA RICARDO
SVP & Chief HR Officer
M - Exercise
Options to purchase Common Stock
-3,818
$0.00
2
$11.43B
2021-10-01
2021-10-05
CHIMINSKI JOHN
Chair & CEO
M - Exercise
Options to purchase Common Stock
-75,838
$0.00
3
$11.43B
2021-10-01
2021-10-05
PRAVDA RICARDO
SVP & Chief HR Officer
M - Exercise
Common Stock
3,818
$63.00
241K
2
$11.43B
2021-10-01
2021-10-05
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-2,055
$132.00
-271K
4
$11.43B
2021-10-01
2021-10-05
PRAVDA RICARDO
SVP & Chief HR Officer
S - Sale
Common Stock
-4,906
$133.00
-652K
1
$11.43B
2021-08-27
2021-08-30
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
S - Sale
Common Stock
-452
$131.00
-59,212
2
$11.43B
2021-08-27
2021-08-30
CASTELLANO THOMAS
SVP, Chief Financial Officer
S - Sale
Common Stock
-2,093
$131.00
-274K
2
$11.43B
2021-08-27
2021-08-30
FASMAN STEVEN
SVP & General Counsel
S - Sale
Common Stock
-6,111
$131.00
-801K
2
$11.43B
2021-08-27
2021-08-30
GENNADIOS ARISTIPPOS
President Softgel & Oral Tech
S - Sale
Common Stock
-2,262
$131.00
-296K
2
$11.43B
2021-08-27
2021-08-30
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-1,698
$131.00
-222K
2
$11.43B
2021-08-27
2021-08-30
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-4,173
$131.00
-547K
3
$11.43B
2021-08-27
2021-08-30
HOPSON RICKY
VP, Chief Accounting Officer
S - Sale
Common Stock
-1,471
$131.00
-193K
2
$11.43B
2021-08-27
2021-08-30
MASELLI ALESSANDRO
President & COO
S - Sale
Common Stock
-3,743
$131.00
-490K
2
$11.43B
2021-08-27
2021-08-30
PRAVDA RICARDO
SVP & Chief HR Officer
S - Sale
Common Stock
-692
$131.00
-90,652
2
$11.43B
2021-08-27
2021-08-30
SCHMIDT KAY
SVP, Technical Operations
S - Sale
Common Stock
-825
$131.00
-108K
2
$11.43B
2021-08-26
2021-08-30
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
A - Grant
Common Stock
7,830
$0.00
1
$11.43B
2021-08-26
2021-08-30
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Common Stock
4,273
$0.00
1
$11.43B
2021-08-26
2021-08-30
GENNADIOS ARISTIPPOS
President Softgel & Oral Tech
A - Grant
Common Stock
8,008
$0.00
1
$11.43B
2021-08-26
2021-08-30
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
4,984
$0.00
1
$11.43B
2021-08-26
2021-08-30
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
6,052
$0.00
1
$11.43B
2021-08-26
2021-08-30
HOPSON RICKY
VP, Chief Accounting Officer
A - Grant
Common Stock
4,317
$0.00
1
$11.43B
2020-01-13
2021-08-23
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-1,680
$58.00
-97,440
1
$11.43B
2019-12-20
2021-08-23
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-2,406
$56.00
-135K
1
$11.43B
2019-12-19
2021-08-23
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-1,846
$54.00
-99,684
1
$11.43B
2021-07-26
2021-07-28
PRAVDA RICARDO
SVP & Chief HR Officer
S - Sale
Common Stock
-458
$113.00
-51,754
1
$11.43B
2021-07-26
2021-07-28
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
A - Grant
Options to purchase Common Stock
4,579
$0.00
1
$11.43B
2021-07-26
2021-07-28
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
A - Grant
Common Stock
885
$0.00
1
$11.43B
2021-07-26
2021-07-28
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Options to purchase Common Stock
5,495
$0.00
1
$11.43B
2021-07-26
2021-07-28
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Common Stock
1,062
$0.00
1
$11.43B
2021-07-26
2021-07-28
CHIMINSKI JOHN
Chair & CEO
A - Grant
Options to purchase Common Stock
85,165
$0.00
1
$11.43B
2021-07-26
2021-07-28
FASMAN STEVEN
SVP & General Counsel
A - Grant
Options to purchase Common Stock
9,158
$0.00
1
$11.43B
2021-07-26
2021-07-28
FLYNN KAREN
Pres. Biologics & CCO
A - Grant
Options to purchase Common Stock
5,953
$0.00
1
$11.43B
2021-07-26
2021-07-28
GENNADIOS ARISTIPPOS
President Softgel & Oral Tech
A - Grant
Options to purchase Common Stock
4,579
$0.00
1
$11.43B
2021-07-26
2021-07-28
GENNADIOS ARISTIPPOS
President Softgel & Oral Tech
A - Grant
Common Stock
885
$0.00
1
$11.43B
2021-07-26
2021-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Options to purchase Common Stock
5,037
$0.00
1
$11.43B
2021-07-26
2021-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
A - Grant
Common Stock
974
$0.00
1
$11.43B
2021-07-26
2021-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Options to purchase Common Stock
3,892
$0.00
1
$11.43B
2021-07-26
2021-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
A - Grant
Common Stock
753
$0.00
1
$11.43B
2021-07-26
2021-07-28
HOPSON RICKY
VP, Chief Accounting Officer
A - Grant
Options to purchase Common Stock
2,565
$0.00
1
$11.43B
2021-07-26
2021-07-28
HOPSON RICKY
VP, Chief Accounting Officer
A - Grant
Common Stock
496
$0.00
1
$11.43B
2021-07-26
2021-07-28
MASELLI ALESSANDRO
President & COO
A - Grant
Options to purchase Common Stock
15,568
$0.00
1
$11.43B
2021-07-26
2021-07-28
PRAVDA RICARDO
SVP & Chief HR Officer
A - Grant
Options to purchase Common Stock
4,579
$0.00
1
$11.43B
2021-07-26
2021-07-28
SCHMIDT KAY
SVP, Technical Operations
A - Grant
Options to purchase Common Stock
4,579
$0.00
1
$11.43B
2021-07-26
2021-07-28
WHITLOW RICCI
President, CSS
A - Grant
Options to purchase Common Stock
2,748
$0.00
1
$11.43B
2021-07-26
2021-07-28
ARNOLD JONATHAN
Pres. Oral & Specialty Deliv.
S - Sale
Common Stock
-120
$113.00
-13,560
1
$11.43B
2021-07-26
2021-07-28
CASTELLANO THOMAS
SVP, Chief Financial Officer
S - Sale
Common Stock
-555
$113.00
-62,715
1
$11.43B
2021-07-26
2021-07-28
FASMAN STEVEN
SVP & General Counsel
S - Sale
Common Stock
-1,549
$113.00
-175K
1
$11.43B
2021-07-26
2021-07-28
GENNADIOS ARISTIPPOS
President Softgel & Oral Tech
S - Sale
Common Stock
-465
$113.00
-52,545
1
$11.43B
2021-07-26
2021-07-28
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
S - Sale
Common Stock
-451
$113.00
-50,963
1
$11.43B
2021-07-26
2021-07-28
GUNTHER SCOTT
SVP, Quality & Reg. Affairs
S - Sale
Common Stock
-1,079
$113.00
-122K
2
$11.43B
2021-07-26
2021-07-28
HOPSON RICKY
VP, Chief Accounting Officer
S - Sale
Common Stock
-360
$113.00
-40,680
1
$11.43B
2021-07-26
2021-07-28
MASELLI ALESSANDRO
President & COO
S - Sale
Common Stock
-993
$113.00
-112K
1
$11.43B
2021-07-26
2021-07-28
SCHMIDT KAY
SVP, Technical Operations
S - Sale
Common Stock
-547
$113.00
-61,811
1
$11.43B
2021-07-15
2021-07-16
FASMAN STEVEN
SVP & General Counsel
S - Sale
Common Stock
-4,500
$110.00
-495K
2
$11.43B
2021-06-23
2021-06-24
PRAVDA RICARDO
SVP & Chief HR Officer
S - Sale
Common Stock
-2,800
$111.00
-311K
1
$11.43B
2021-06-01
2021-06-02
CASTELLANO THOMAS
SVP, Chief Financial Officer
A - Grant
Common Stock
2,451
$0.00
1
$11.43B
2021-06-01
2021-06-02
HOPSON RICKY
VP, Chief Accounting Officer
A - Grant
Common Stock
3,432
$0.00
1
$11.43B
2021-05-10
2021-05-24
GRIPPO MICHAEL
SVP, Strategy & Corp. Dev.
G - Gift
Common Stock
-20
$0.00
2
$11.43B